January 13, 2015

News

MangoGen's News

December 2018b

MangoGen and Orgenesis (NASDAQ:ORGS) announce a collaboration funded by the Canada-Israel Industrial R&D Foundation (CIIRDF) to develop cell therapies to treat diabetes using MangoGen’s baculoviral gene-delivery technology.

December 2018a

MangoGen are pleased to announce that Francois Castconguay has agreed to be a non-executive director on the MangoGen Board. Mr Castconguary retired as CEO of Uniprix in 2015 and will bring 25+ years of executive experience.

August 2018

MangoGen are pleased to announce the granting of our umbrella patent in the USA (#10,092,602 B2)
(from L-R: Alain Labbe, Paul Plested, Satya Prakash)

March 2018

MangoGen are pleased to announce the addition of Dr. Bradley Thompson to the MangoGen Board as a Non-Executive Director. Dr Thompson was previously CEO and Co-Founder of Oncolytics Biotech (ONCY) based in Calgary, Canada.

February 2018b

Paul Plested CEO presented MangoGen Pharma at the European Life Sciences CEO Forum in Zurich on February 26th 2018  

February 2018a

Paul Plested CEO presented MangoGen Pharma at Biotech and Money World Conference in London on February 6th 2018  

January 2018

Paul Plested CEO presented MangoGen Pharma at Biotech Showcase in San Francisco on January 10th 2018

November 2017

Paul Plested CEO presented MangoGen Pharma at Life Sciences Summit in New York on November 2nd 2017.

September 2017

The MangoGen Team back in Jinan City, Shandong Province, with Satya Prakash, President of MangoGen Pharma receiving a prodigious Foreign Expert Award from the Jinan Municipal People’s Government. Alongside Satya are Dr. Paul Plested MangoGen’s CEO, and Dr. Alain Labbe, MangoGen’s Chief Scientific Officer. Also present was Mr. Ma (right of Dr. Labbe), CEO of MaiGao Genetic Coating Co Ltd, MangoGen’s sister organization in China.

May 2017

MangoGen’s patent is GRANTED in Australia

October 2016

Paul Plested (CEO) and Satya Prakash (President) presented MangoGen Pharma at the High Level Overseas Talent and Projects Conference in Jinan, Shandong Province, PR China

July 2016

Paul Plested (CEO) and Alain Labbe (Director of R&D), travel to Jinan to discuss aspects of technology transfer to China.

Top left to right: Meeting the China Team of MaiGao Genetic Company Co Ltd.; Paul and Alain with Mr Ma, Chairman of MaiGao; The New Building; Bottom left to rightAlain and Paul on The WallTime Out on The Wall, Alain with Lydia and our guide “Elvis”; The Team discussing new laboratory and production space.

Older News

February 2016

MangoGen employ 2 new Technicians – Rafael and Alain M.

January 2016

MangoGen awarded an IRAP Grant from the Canadian Government – US$ 140,000 over 16 months

August 21st 2015

MangoGen’s new corporate telephone line is 1-514-800-6872

July 1st 2015

MangoGen’s laboratory, located at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC., becomes fully operational.

June 1st 2015

MangoGen appoints Dr Alain Labbe as Director of Research & Development.

June 1st 2015

MangoGen is accepted into the full incubation program at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC.

June 1st 2015

MangoGen complete signing of US$ 1.67 million seed investment from GP HealthCare, Jinan, Shandong Province, PR China.

January 5th 2015

MangoGen enters the pre-incubation program at the le Centre québécois d’innovation en biotechnologie (CQIB) in Laval, QC.

 

 

2019